1. Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition. Issue 4 (7th March 2022) Authors: Schneeweis, Christian; Hassan, Zonera; Ascherl, Katja; Wirth, Matthias; Koutsouli, Stella; Orben, Felix; Krauß, Lukas; Schneider, Carolin; Öllinger, Rupert; Krämer, Oliver H.; Rad, Roland; Reichert, Maximilian; Robles, Maria S.; Saur, Dieter; Schneider, Günter Journal: Cancer communications Issue: Volume 42:Issue 4(2022) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53‐independent pancreatic cancer cell death. Issue 10 (26th November 2012) Authors: Conradt, Laura; Henrich, Annika; Wirth, Matthias; Reichert, Maximilian; Lesina, Marina; Algül, Hana; Schmid, Roland M.; Krämer, Oliver H.; Saur, Dieter; Schneider, Günter Journal: International journal of cancer Issue: Volume 132:Issue 10(2013:May 15) Page Start: 2248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib. Issue 16 (21st August 2014) Authors: Wirth, Matthias; Stojanovic, Natasa; Christian, Jan; Paul, Mariel C.; Stauber, Roland H.; Schmid, Roland M.; Häcker, Georg; Krämer, Oliver H.; Saur, Dieter; Schneider, Günter Journal: Nucleic acids research Issue: Volume 42:Issue 16(2014) Page Start: 10433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis—A connection to licensing nodes. (2nd November 2018) Authors: Schneeweis, Christian; Wirth, Matthias; Saur, Dieter; Reichert, Maximilian; Schneider, Günter Journal: Small GTPases Issue: Volume 9:Number 6(2018) Page Start: 457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype. Issue 8 (30th January 2020) Authors: Biederstädt, Alexander; Hassan, Zonera; Schneeweis, Christian; Schick, Markus; Schneider, Lara; Muckenhuber, Alexander; Hong, Yingfen; Siegers, Gerrit; Nilsson, Lisa; Wirth, Matthias; Dantes, Zahra; Steiger, Katja; Schunck, Kathrin; Langston, Steve; Lenhof, H-P; Coluccio, Andrea; Orben, Felix; Sl... Journal: Gut Issue: Volume 69:Issue 8(2020) Page Start: 1472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC. Issue 12 (8th November 2020) Authors: Lankes, Katharina; Hassan, Zonera; Doffo, María Josefina; Schneeweis, Christian; Lier, Svenja; Öllinger, Rupert; Rad, Roland; Krämer, Oliver H.; Keller, Ulrich; Saur, Dieter; Reichert, Maximilian; Schneider, Günter; Wirth, Matthias Journal: Molecular oncology Issue: Volume 14:Issue 12(2020) Page Start: 3048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The OTUD6B‐LIN28B‐MYC axis determines the proliferative state in multiple myeloma. (5th September 2022) Authors: Paulmann, Carmen; Spallek, Ria; Karpiuk, Oleksandra; Heider, Michael; Schäffer, Isabell; Zecha, Jana; Klaeger, Susan; Walzik, Michaela; Öllinger, Rupert; Engleitner, Thomas; Wirth, Matthias; Keller, Ulrich; Krönke, Jan; Rudelius, Martina; Kossatz, Susanne; Rad, Roland; Kuster, Bernhard; Basserman... Journal: EMBO journal Issue: Volume 41:Number 20(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗